IDEXX Laboratories Q3 EPS $4.01 Beats $3.71 Estimate, Sales $1.214B Beat $1.191B Estimate

IDEXX Laboratories (NASDAQ:IDXX) reported quarterly earnings of $4.01 per share which beat the analyst consensus estimate of $3.71 by 8.09 percent. This is a 17.94 percent increase over earnings of $3.40 per share from the same period last year. The company reported quarterly sales of $1.214 billion which beat the analyst consensus estimate of $1.191 billion by 1.94 percent. This is a 9.86 percent increase over sales of $1.105 billion the same period last year.